EGFR-TK1-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients with NSCLC: When Is it Worth The Risk?
Saved in:
| Title: | EGFR-TK1-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients with NSCLC: When Is it Worth The Risk? |
|---|---|
| Authors: | Mormile R; Division of Pediatrics and Neonatology, Moscati Hospital, Via A. Gramsci, 81031, Aversa, Italy. raffaellamormile@alice.it. |
| Source: | Pathology oncology research : POR [Pathol Oncol Res] 2019 Oct; Vol. 25 (4), pp. 1665-1666. Date of Electronic Publication: 2019 Jan 19. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 9706087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2807 (Electronic) Linking ISSN: 12194956 NLM ISO Abbreviation: Pathol Oncol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1532-2807 |
|---|---|
| DOI: | 10.1007/s12253-019-00599-z |
